LSE:DXRX
Diaceutics PLC · LSE · Healthcare · GBP · FY for 2025
Figures on this page computed 2026-11-08 13:20 UTC
Last close
n/aGBp
Market data
1822.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- computed
- Computed from the filing for 2025
0.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- GBp
- computed
Price is the furthest below its sector's middle: 0.16 against 0.36 on the market's range.
- Growth24.8%58 of 100, above its sector
- Returns on capital0.3%38 of 100, above its sector
- Margins68.0%56 of 100, above its sector
- Price1822.7x16 of 100, below its sector
- Safety0.0376 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.